Friday, February 28, 2020
Home Clinical Trials

Clinical Trials

Study finds picosecond more effective than Q-switched laser at eyebrow tattoo removal

A study of brown and black ink eyebrow-tattoo removal using laser in four patients presented several advantages to using picosecond over...

New Data from Revian Red: System Shown to Support Hair Growth

The Revian Red hair growth system demonstrates the ability to successfully stop hair loss and subsequently grow new hair, according to final data from...

Editors’ Choice: Medical Aesthetics in 2019

2019 was an exciting year for Medical Aesthetics, a year of cosmetic self-reflection focused on selfies and social media, driven by controversies around buttock augmentation...

Study suggests use of gold microparticles and laser improves acne

A study presented at the America Society for Dermatologic Surgery annual meeting has shown that combining the use of gold microparticles with...

Study highlights inaccuracy of eczema apps

A study published in the British Journal of Dermatology has suggested that 34% of eczema smartphone apps contain information that is inconsistent...

Study demonstrates high patient satisfaction with Azzalure

The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure...
- Advertisment -

Most Read

BioScience launches new range of monophasic dermal fillers

Aesthetic product manufacturer BioScience GmbH has launched HYAProf, a new injectable line which combines monodensified and polydensified dermal fillers.

Aesthetics Biomedical Announces Molly Sims as SoME™ Skincare Brand Ambassador

The innovators at Aesthetics Biomedical (ABM), a leading aesthetics product development corporation, proudly welcome Molly Sims as Brand Ambassador for SoME™ Skincare That's All...

FDA approves Cynosure’s Potenza radiofrequency microneedling device

Medical aesthetics company Cynosure has secured approval from the US Food and Drug Administration (FDA) for its Potenza radiofrequency (RF) microneedling device.

Business News: Lilly, Dermira Acquisition Complete

The acquisition expands Lilly's immunology pipeline with lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 that is being evaluated for...